Ergoteles LLC Pfizer Inc Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $169,630 - $221,433	4,063 Added 16.55%	28,606 $1.47 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.48 Million - $1.81 Million	-33,821 Reduced 57.95%	24,543 $1.07 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $1 Million - $1.19 Million	21,598 Added 58.74%	58,364 $3.06 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $970,311 - $1.2 Million	21,209 Added 136.33%	36,766 $1.9 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $642,815 - $952,866	15,557 New	15,557 $919,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.